Biotech Updates

Australian OGTR Receives Application for Field Trial of GM Perennial Ryegrass

September 21, 2022

Australia's Office of the Gene Technology Regulator (OGTR) has received license application DIR 194 from Grasslanz Technology Australia to conduct a field trial of genetically modified (GM) perennial ryegrass with increased metabolizable energy content.

The field trial is proposed to take place between April 2023 and December 2028 with a maximum area of 2.5 hectares per year, and up to 12.5 hectares in total over the duration of the trial. Seven trial sites would be used per year, chosen from 119 local government areas in New South Wales, Victoria, Western Australia, and Queensland.

The GM perennial ryegrass grown in the field trial would not be used for commercial animal feed. However, animal feeding trials may be undertaken with silage produced from the GM perennial ryegrass. The OGTR is now preparing a Risk Assessment and Risk Management Plan for the application, expected to be released for public comment and advice from experts, agencies, and authorities in late November 2022.

For more details about this field trial, visit the DIR 194 page on the OGTR website.

You might also like: